Filing Details
- Accession Number:
- 0001562180-19-000860
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-08 18:32:46
- Reporting Period:
- 2019-02-07
- Accepted Time:
- 2019-02-08 18:32:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1609284 | A Nicholas Saccomano | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | Cso | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-07 | 82,500 | $3.00 | 224,988 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-07 | 104,764 | $4.20 | 329,752 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-07 | 187,264 | $21.58 | 142,488 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-07 | 104,764 | $0.00 | 104,764 | $4.20 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-07 | 82,500 | $0.00 | 82,500 | $3.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-05-30 | No | 4 | M | Direct | |
| 82,500 | 2026-04-01 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $21.50 to $21.785. Details of actual prices for shares sold are available from the Issuer upon request.
- The option vests in four equal annual installments beginning May 30, 2015.
- The option vests in four equal annual installments beginning on April 1, 2017.
Billionaire Hedge Funds
